About
InterMune develops biopharmaceutical therapies targeting rare and serious diseases, with a focus on pulmonary and fibrotic conditions such as pulmonary fibrosis.
Explore InterMune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.